Clinical OMICS

MAY-JUN 2019

Healthcare magazine for research scientists, labs, pathologists, hospitals, cancer centers, physicians and biopharma companies providing news articles, expert interviews and videos about molecular diagnostics in precision medicine

Issue link:

Contents of this Issue


Page 39 of 50

38 Clinical OMICs May/June 2019 38 Clinical OMICs May/June 2019 A decade ago this October, systems biology pioneer Leroy Hood, M.D., Ph.D., and the Institute for Systems Biology that he co-founded announced a collaboration with Ohio State University to develop what is now the P4 Medicine Institute. "P4" medicine was Hood's visionary paradigm that healthcare must evolve from being reactionary to being "predictive, preventive, personalized, and participatory." That paradigm is also known as precision medicine, a market whose value was pegged at $38.92 billion in 2015—and is expected to more than double by 2022, to $88.64 billion, according to Market Research Future. Here we profile 10 companies to watch for their ambitious, and so far successful, application of "omics" technologies and clinical genetic insights to deliver on the promise of precision medicine: Alex Philippidis Senior News Editor Up-and-Coming Companies Fulfilling the Promise of Precision Medicine 10 to Watch hanut iamnoy / iStock / Getty Images

Articles in this issue

Links on this page

Archives of this issue

view archives of Clinical OMICS - MAY-JUN 2019